Table 3 In-hospital outcomes of patients undergoing tricuspid valve surgery for isolated rheumatic tricuspid regurgitation (n = 26) with comparison between tricuspid valve repair group and tricuspid valve replacement group. Data are Presented as Mean ± SD, Median (Range), or n (%)
From: Reoperation for isolated rheumatic tricuspid regurgitation
Characteristics | All patients n = 26 | TV repair n = 15 | TV replacement n = 11 | p-Value |
|---|---|---|---|---|
Ventilator support (hours) | 12.5 (3–120) | 9 (3–96) | 17 (4–120) | 0.47 |
ICU stay (hours) | 71.4 ± 38.8 | 73.1 ± 44.4 | 69 ± 31.6 | 0.79 |
Postoperative stay (days) | 16.9 ± 10.1 | 14.7 ± 10.8 | 19.8 ± 8.7 | 0.21 |
30-day mortality | 4 (15.4%) | 3 (20%) | 1 (9.1%) | 0.61 |
Low cardiac output syndrome | 7 (26.9%) | 4 (26.7%) | 3 (27.3%) | 1 |
Transitory renal failure | 8 (30.8%) | 5 (33.3%) | 3 (27.3%) | 0.54 |
Pneumonia | 6 (23.1%) | 4 (26.7%) | 2 (18.2%) | 1 |
Red Blood Cells transfusion > 1 unit | 10 (55.6%) | 5 (41.7%) | 5 (83.3%) | 0.15 |
Bleeding | 6 (23.1%) | 4 (26.7%) | 2 (18.2%) | 1 |
Reexploration for bleeding | 3 (11.5%) | 2 (13.3%) | 1 (9.1%) | 0.62 |
Sternal wound infection | 1 (3.8%) | 1 (6.7%) | 0 (0%) | 0.58 |
Sepsis | 2 (7.7%) | 1 (6.7%) | 1 (9.1%) | 1 |
Cardiac complication | 11 (42.3%) | 6 (40%) | 5 (45.5%) | 1 |
Respiratory complication | 7 (26.9%) | 4 (26.7%) | 3 (27.3%) | 0.66 |
Infective complication | 7 (26.9%) | 4 (26.7%) | 3 (27.3%) | 1 |
Renal complication | 8 (30.8%) | 5 (33.3%) | 3 (27.3%) | 1 |
Neurologic complications | 1 (3.8%) | 1 (6.7%) | 0 (0%) | 1 |